Medifast (MED) Tops Q1 EPS by 12c, Misses on Revenue
Tweet
Share
E-mail
Get Alerts MED Hot Sheet
Price: $12.14 --0%
Revenue Growth %: -24.3%
Financial Fact:
Diluted earnings per share: 0.51
Today's EPS Names:
PMCB, PLCE, DOMO, More
Revenue Growth %: -24.3%
Financial Fact:
Diluted earnings per share: 0.51
Today's EPS Names:
PMCB, PLCE, DOMO, More
Join SI Premium – FREE
Medifast (NYSE: MED) reported Q1 EPS of ($0.07), $0.12 better than the analyst estimate of ($0.19). Revenue for the quarter came in at $115.7 million versus the consensus estimate of $130.75 million.
GUIDANCE:
Medifast sees Q2 2025 revenue of $85-105 million.
For earnings history and earnings-related data on Medifast (MED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies Starts Latigo Biotherapeutics (LTGO) at Buy
- Piper Sandler Upgrades Capricor Therapeutics (CAPR) to Overweight 'Ahead of Extended 11/22 PDUFA Date'
- Piper Sandler Upgrades Tempus AI Inc (TEM) to Overweight, 'On A Train Back To Upside, We're Not Jumping the Gun'
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
